ASCO 2026: key news stories

Events coverage News Quality of life and outcomes

With the cancer research and care community eagerly awaiting the beginning of the biggest meeting in clinical oncology - ASCO (May 29 to June 2, IL, USA) - we're delighted to present you with key news headlines. Make sure to check back throughout the conference, as we will be continually adding news stories as they break. frontMIND trial: improved progression free survival outcomes for aggressive B-cell lymphoma Results from the Phase III frontMIND trial show that adding tafasitamab and lenalidomide to R-CHOP for first-line treatment can reduce tumor progression in people with aggressive diffuse large B-cell lymphoma or high-grade B-cell...

To view this content, please register now for access

It's completely free